APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Implantable Drug Eluting Stent

Compare research editions
View pricing & licenses

Selected research

Industry Research

Implantable Drug Eluting Stent Industry Research Report 2026

Report ID 173909550527 December 2025127 pages

Choose your research edition.

Industry ResearchImplantable Drug Eluting Stent Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Drug Eluting Stent Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Implantable Drug Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Drug Eluting Stent Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Drug Eluting Stent Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Implantable Drug Eluting Stent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Implantable Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Implantable Drug Eluting Stent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Implantable Drug Eluting Stent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Implantable Drug Eluting Stent include Cook, Drug-eluting Stent, Terumo, Boston Scientific, Lepu Medical, Medtronic, Beijing Amsino Medical, SINOMED and Microport Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Implantable Drug Eluting Stent market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Implantable Drug Eluting Stent Market by Company

Cook

Drug-eluting Stent

Terumo

Boston Scientific

Lepu Medical

Medtronic

Beijing Amsino Medical

SINOMED

Microport Medical

Abbott

Yinyi Biotech

Implantable Drug Eluting Stent Segment by Type

Rapamycin

Everolimus

Paclitaxel

Other

Implantable Drug Eluting Stent Segment by Application

Coronary

Peripheral Vascular

Others

Implantable Drug Eluting Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Drug Eluting Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Drug Eluting Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Drug Eluting Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Implantable Drug Eluting Stent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Implantable Drug Eluting Stent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Implantable Drug Eluting Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Implantable Drug Eluting Stent Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Implantable Drug Eluting Stent Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Implantable Drug Eluting Stent Sales Market Share by Manufacturers (2021-2026) Table 8. Global Implantable Drug Eluting Stent Revenue of Manufacturers (2021-2026) Table 9. Global Implantable Drug Eluting Stent Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Implantable Drug Eluting Stent Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Implantable Drug Eluting Stent Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Implantable Drug Eluting Stent, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Implantable Drug Eluting Stent, Product Type & Application Table 14. Global Implantable Drug Eluting Stent Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Implantable Drug Eluting Stent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Cook Company Information Table 19. Cook Business Overview Table 20. Cook Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Cook Implantable Drug Eluting Stent Product Portfolio Table 22. Cook Recent Developments Table 23. Drug-eluting Stent Company Information Table 24. Drug-eluting Stent Business Overview Table 25. Drug-eluting Stent Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Drug-eluting Stent Implantable Drug Eluting Stent Product Portfolio Table 27. Drug-eluting Stent Recent Developments Table 28. Terumo Company Information Table 29. Terumo Business Overview Table 30. Terumo Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Terumo Implantable Drug Eluting Stent Product Portfolio Table 32. Terumo Recent Developments Table 33. Boston Scientific Company Information Table 34. Boston Scientific Business Overview Table 35. Boston Scientific Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Boston Scientific Implantable Drug Eluting Stent Product Portfolio Table 37. Boston Scientific Recent Developments Table 38. Lepu Medical Company Information Table 39. Lepu Medical Business Overview Table 40. Lepu Medical Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Lepu Medical Implantable Drug Eluting Stent Product Portfolio Table 42. Lepu Medical Recent Developments Table 43. Medtronic Company Information Table 44. Medtronic Business Overview Table 45. Medtronic Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Medtronic Implantable Drug Eluting Stent Product Portfolio Table 47. Medtronic Recent Developments Table 48. Beijing Amsino Medical Company Information Table 49. Beijing Amsino Medical Business Overview Table 50. Beijing Amsino Medical Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Beijing Amsino Medical Implantable Drug Eluting Stent Product Portfolio Table 52. Beijing Amsino Medical Recent Developments Table 53. SINOMED Company Information Table 54. SINOMED Business Overview Table 55. SINOMED Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. SINOMED Implantable Drug Eluting Stent Product Portfolio Table 57. SINOMED Recent Developments Table 58. Microport Medical Company Information Table 59. Microport Medical Business Overview Table 60. Microport Medical Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Microport Medical Implantable Drug Eluting Stent Product Portfolio Table 62. Microport Medical Recent Developments Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Abbott Implantable Drug Eluting Stent Product Portfolio Table 67. Abbott Recent Developments Table 68. Yinyi Biotech Company Information Table 69. Yinyi Biotech Business Overview Table 70. Yinyi Biotech Implantable Drug Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Yinyi Biotech Implantable Drug Eluting Stent Product Portfolio Table 72. Yinyi Biotech Recent Developments Table 73. Global Implantable Drug Eluting Stent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Implantable Drug Eluting Stent Sales by Region (2021-2026) & (K Units) Table 75. Global Implantable Drug Eluting Stent Sales Market Share by Region (2021-2026) Table 76. Global Implantable Drug Eluting Stent Sales by Region (2027-2032) & (K Units) Table 77. Global Implantable Drug Eluting Stent Sales Market Share by Region (2027-2032) Table 78. Global Implantable Drug Eluting Stent Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Implantable Drug Eluting Stent Revenue Market Share by Region (2021-2026) Table 80. Global Implantable Drug Eluting Stent Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Implantable Drug Eluting Stent Revenue Market Share by Region (2027-2032) Table 82. North America Implantable Drug Eluting Stent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 84. North America Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 85. North America Implantable Drug Eluting Stent Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Implantable Drug Eluting Stent Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Implantable Drug Eluting Stent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 89. Europe Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 90. Europe Implantable Drug Eluting Stent Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Implantable Drug Eluting Stent Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Implantable Drug Eluting Stent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Implantable Drug Eluting Stent Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Implantable Drug Eluting Stent Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Implantable Drug Eluting Stent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 99. South America Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 100. South America Implantable Drug Eluting Stent Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Implantable Drug Eluting Stent Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Implantable Drug Eluting Stent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Implantable Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Implantable Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Implantable Drug Eluting Stent Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Implantable Drug Eluting Stent Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Implantable Drug Eluting Stent Sales by Type (2021-2026) & (K Units) Table 108. Global Implantable Drug Eluting Stent Sales by Type (2027-2032) & (K Units) Table 109. Global Implantable Drug Eluting Stent Sales Market Share by Type (2021-2026) Table 110. Global Implantable Drug Eluting Stent Sales Market Share by Type (2027-2032) Table 111. Global Implantable Drug Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Implantable Drug Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021-2026) Table 114. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2027-2032) Table 115. Global Implantable Drug Eluting Stent Price by Type (2021-2026) & (US$/Unit) Table 116. Global Implantable Drug Eluting Stent Price by Type (2027-2032) & (US$/Unit) Table 117. Global Implantable Drug Eluting Stent Sales by Application (2021-2026) & (K Units) Table 118. Global Implantable Drug Eluting Stent Sales by Application (2027-2032) & (K Units) Table 119. Global Implantable Drug Eluting Stent Sales Market Share by Application (2021-2026) Table 120. Global Implantable Drug Eluting Stent Sales Market Share by Application (2027-2032) Table 121. Global Implantable Drug Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Implantable Drug Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021-2026) Table 124. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2027-2032) Table 125. Global Implantable Drug Eluting Stent Price by Application (2021-2026) & (US$/Unit) Table 126. Global Implantable Drug Eluting Stent Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Implantable Drug Eluting Stent Distributors List Table 130. Implantable Drug Eluting Stent Customers List Table 131. Implantable Drug Eluting Stent Industry Trends Table 132. Implantable Drug Eluting Stent Industry Drivers Table 133. Implantable Drug Eluting Stent Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Implantable Drug Eluting Stent Product Image Figure 5. Global Implantable Drug Eluting Stent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Implantable Drug Eluting Stent Market Size (2021-2032) & (US$ Million) Figure 7. Global Implantable Drug Eluting Stent Sales (2021-2032) & (K Units) Figure 8. Global Implantable Drug Eluting Stent Average Price (US$/Unit) & (2021-2032) Figure 9. Rapamycin Product Image Figure 10. Everolimus Product Image Figure 11. Paclitaxel Product Image Figure 12. Other Product Image Figure 13. Coronary Product Image Figure 14. Peripheral Vascular Product Image Figure 15. Others Product Image Figure 16. Global Implantable Drug Eluting Stent Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Implantable Drug Eluting Stent, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Implantable Drug Eluting Stent Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Implantable Drug Eluting Stent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Implantable Drug Eluting Stent Sales by Region in 2025 Figure 22. Global Implantable Drug Eluting Stent Revenue by Region in 2025 Figure 23. North America Implantable Drug Eluting Stent Market Size by Country in 2025 Figure 24. North America Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 25. North America Implantable Drug Eluting Stent Revenue Market Share by Country (2021-2032) Figure 26. United States Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Implantable Drug Eluting Stent Market Size by Country in 2025 Figure 30. Europe Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 31. Europe Implantable Drug Eluting Stent Revenue Market Share by Country (2021-2032) Figure 32. Germany Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Implantable Drug Eluting Stent Market Size by Country in 2025 Figure 43. Asia Pacific Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Implantable Drug Eluting Stent Revenue Market Share by Country (2021-2032) Figure 45. China Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Implantable Drug Eluting Stent Market Size by Country in 2025 Figure 54. South America Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 55. South America Implantable Drug Eluting Stent Revenue Market Share by Country (2021-2032) Figure 56. Brazil Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Implantable Drug Eluting Stent Market Size by Country in 2025 Figure 60. Middle East and Africa Implantable Drug Eluting Stent Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Implantable Drug Eluting Stent Revenue Market Share by Country (2021-2032) Figure 62. Egypt Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Implantable Drug Eluting Stent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Implantable Drug Eluting Stent Sales Market Share by Type (2021-2032) Figure 68. Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021-2032) Figure 69. Global Implantable Drug Eluting Stent Price (US$/Unit) by Type (2021-2032) Figure 70. Global Implantable Drug Eluting Stent Sales Market Share by Application (2021-2032) Figure 71. Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021-2032) Figure 72. Global Implantable Drug Eluting Stent Price (US$/Unit) by Application (2021-2032) Figure 73. Implantable Drug Eluting Stent Value Chain Figure 74. Implantable Drug Eluting Stent Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Implantable Drug Eluting Stent Industry Opportunities and Challenges

Scope & coverage.

Types
  • Rapamycin
  • Everolimus
  • Paclitaxel
  • Other
Applications
  • Coronary
  • Peripheral Vascular
  • Others
Companies covered
  • Cook
  • Drug-eluting Stent
  • Terumo
  • Boston Scientific
  • Lepu Medical
  • Medtronic
  • Beijing Amsino Medical
  • SINOMED
  • Microport Medical
  • Abbott
  • Yinyi Biotech

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Implantable Drug Eluting Stent Market Size (2021-2032)
  4. 2.2.2 Global Implantable Drug Eluting Stent Sales (2021-2032)
  5. 2.2.3 Global Implantable Drug Eluting Stent Market Average Price (2021-2032)
  6. 2.3 Implantable Drug Eluting Stent by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Rapamycin
  9. 2.3.3 Everolimus
  10. 2.3.4 Paclitaxel
  11. 2.3.5 Other
  12. 2.4 Implantable Drug Eluting Stent by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Coronary
  15. 2.4.3 Peripheral Vascular
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Implantable Drug Eluting Stent Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Implantable Drug Eluting Stent Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Implantable Drug Eluting Stent Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Implantable Drug Eluting Stent Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Implantable Drug Eluting Stent Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Implantable Drug Eluting Stent, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Implantable Drug Eluting Stent, Product Type & Application
  8. 3.8 Global Manufacturers of Implantable Drug Eluting Stent, Established Date
  9. 3.9 Global Implantable Drug Eluting Stent Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Cook
  2. 4.1.1 Cook Company Information
  3. 4.1.2 Cook Business Overview
  4. 4.1.3 Cook Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Cook Implantable Drug Eluting Stent Product Portfolio
  6. 4.1.5 Cook Recent Developments
  7. 4.2 Drug-eluting Stent
  8. 4.2.1 Drug-eluting Stent Company Information
  9. 4.2.2 Drug-eluting Stent Business Overview
  10. 4.2.3 Drug-eluting Stent Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Drug-eluting Stent Implantable Drug Eluting Stent Product Portfolio
  12. 4.2.5 Drug-eluting Stent Recent Developments
  13. 4.3 Terumo
  14. 4.3.1 Terumo Company Information
  15. 4.3.2 Terumo Business Overview
  16. 4.3.3 Terumo Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Terumo Implantable Drug Eluting Stent Product Portfolio
  18. 4.3.5 Terumo Recent Developments
  19. 4.4 Boston Scientific
  20. 4.4.1 Boston Scientific Company Information
  21. 4.4.2 Boston Scientific Business Overview
  22. 4.4.3 Boston Scientific Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Boston Scientific Implantable Drug Eluting Stent Product Portfolio
  24. 4.4.5 Boston Scientific Recent Developments
  25. 4.5 Lepu Medical
  26. 4.5.1 Lepu Medical Company Information
  27. 4.5.2 Lepu Medical Business Overview
  28. 4.5.3 Lepu Medical Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Lepu Medical Implantable Drug Eluting Stent Product Portfolio
  30. 4.5.5 Lepu Medical Recent Developments
  31. 4.6 Medtronic
  32. 4.6.1 Medtronic Company Information
  33. 4.6.2 Medtronic Business Overview
  34. 4.6.3 Medtronic Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Medtronic Implantable Drug Eluting Stent Product Portfolio
  36. 4.6.5 Medtronic Recent Developments
  37. 4.7 Beijing Amsino Medical
  38. 4.7.1 Beijing Amsino Medical Company Information
  39. 4.7.2 Beijing Amsino Medical Business Overview
  40. 4.7.3 Beijing Amsino Medical Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Beijing Amsino Medical Implantable Drug Eluting Stent Product Portfolio
  42. 4.7.5 Beijing Amsino Medical Recent Developments
  43. 4.8 SINOMED
  44. 4.8.1 SINOMED Company Information
  45. 4.8.2 SINOMED Business Overview
  46. 4.8.3 SINOMED Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 SINOMED Implantable Drug Eluting Stent Product Portfolio
  48. 4.8.5 SINOMED Recent Developments
  49. 4.9 Microport Medical
  50. 4.9.1 Microport Medical Company Information
  51. 4.9.2 Microport Medical Business Overview
  52. 4.9.3 Microport Medical Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Microport Medical Implantable Drug Eluting Stent Product Portfolio
  54. 4.9.5 Microport Medical Recent Developments
  55. 4.10 Abbott
  56. 4.10.1 Abbott Company Information
  57. 4.10.2 Abbott Business Overview
  58. 4.10.3 Abbott Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Abbott Implantable Drug Eluting Stent Product Portfolio
  60. 4.10.5 Abbott Recent Developments
  61. 4.11 Yinyi Biotech
  62. 4.11.1 Yinyi Biotech Company Information
  63. 4.11.2 Yinyi Biotech Business Overview
  64. 4.11.3 Yinyi Biotech Implantable Drug Eluting Stent Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Yinyi Biotech Implantable Drug Eluting Stent Product Portfolio
  66. 4.11.5 Yinyi Biotech Recent Developments
5 Global Implantable Drug Eluting Stent Market Scenario by Region
  1. 5.1 Global Implantable Drug Eluting Stent Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Implantable Drug Eluting Stent Sales by Region: 2021-2032
  3. 5.2.1 Global Implantable Drug Eluting Stent Sales by Region: 2021-2026
  4. 5.2.2 Global Implantable Drug Eluting Stent Sales by Region: 2027-2032
  5. 5.3 Global Implantable Drug Eluting Stent Revenue by Region: 2021-2032
  6. 5.3.1 Global Implantable Drug Eluting Stent Revenue by Region: 2021-2026
  7. 5.3.2 Global Implantable Drug Eluting Stent Revenue by Region: 2027-2032
  8. 5.4 North America Implantable Drug Eluting Stent Market Facts & Figures by Country
  9. 5.4.1 North America Implantable Drug Eluting Stent Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Implantable Drug Eluting Stent Sales by Country (2021-2032)
  11. 5.4.3 North America Implantable Drug Eluting Stent Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Implantable Drug Eluting Stent Market Facts & Figures by Country
  16. 5.5.1 Europe Implantable Drug Eluting Stent Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Implantable Drug Eluting Stent Sales by Country (2021-2032)
  18. 5.5.3 Europe Implantable Drug Eluting Stent Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Implantable Drug Eluting Stent Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Implantable Drug Eluting Stent Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Implantable Drug Eluting Stent Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Implantable Drug Eluting Stent Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Implantable Drug Eluting Stent Market Facts & Figures by Country
  41. 5.7.1 South America Implantable Drug Eluting Stent Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Implantable Drug Eluting Stent Sales by Country (2021-2032)
  43. 5.7.3 South America Implantable Drug Eluting Stent Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Implantable Drug Eluting Stent Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Implantable Drug Eluting Stent Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Implantable Drug Eluting Stent Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Implantable Drug Eluting Stent Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Implantable Drug Eluting Stent Sales by Type (2021-2032)
  2. 6.1.1 Global Implantable Drug Eluting Stent Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Implantable Drug Eluting Stent Sales Market Share by Type (2021-2032)
  4. 6.2 Global Implantable Drug Eluting Stent Revenue by Type (2021-2032)
  5. 6.2.1 Global Implantable Drug Eluting Stent Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Implantable Drug Eluting Stent Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Implantable Drug Eluting Stent Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Implantable Drug Eluting Stent Sales by Application (2021-2032)
  2. 7.1.1 Global Implantable Drug Eluting Stent Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Implantable Drug Eluting Stent Sales Market Share by Application (2021-2032)
  4. 7.2 Global Implantable Drug Eluting Stent Revenue by Application (2021-2032)
  5. 7.2.1 Global Implantable Drug Eluting Stent Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Implantable Drug Eluting Stent Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Implantable Drug Eluting Stent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Implantable Drug Eluting Stent Value Chain Analysis
  2. 8.1.1 Implantable Drug Eluting Stent Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Implantable Drug Eluting Stent Production Mode & Process
  5. 8.2 Implantable Drug Eluting Stent Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Implantable Drug Eluting Stent Distributors
  8. 8.2.3 Implantable Drug Eluting Stent Customers
9 Global Implantable Drug Eluting Stent Analyzing Market Dynamics
  1. 9.1 Implantable Drug Eluting Stent Industry Trends
  2. 9.2 Implantable Drug Eluting Stent Industry Drivers
  3. 9.3 Implantable Drug Eluting Stent Industry Opportunities and Challenges
  4. 9.4 Implantable Drug Eluting Stent Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst